title: Intraoperative coronary vein graft thrombosis: should we blame the use of aprotinin?
authors.forename: S
authors.initials: S
authors.lastname: Sivasubramaniam
authors.forename: B
authors.initials: B
authors.lastname: Murali
authors.forename: C J
authors.initials: CJ
authors.lastname: Smallpiece
authors.forename: Bac
authors.initials: B
authors.lastname: Smith
authors.forename: M
authors.initials: M
authors.lastname: Kalkat
mesh_terms: D000368:Aged; D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000139:chemically induced* / Q000601:surgery; D005260:Female; D006490:Hemostatics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced* / Q000601:surgery; D011300:Preoperative Care / Q000379:methods; D016896:Treatment Outcome
chemical_list: D006490:Hemostatics; D007611:Aprotinin